Jubilant Ingrevia Q2 profit rises 61%, shares gain as much as 8%
Jubilant Ingrevia's net profit for the September quarter rose 61.4% and revenue 24.4%, lifting its shares more than 8% on Tuesday.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Shares of Indian specialty chemicals maker Jubilant Ingrevia rose more than 8% on Tuesday, October 27. According to TradingView, the company reported a strong September quarter of financial year 2026-27, with net profit of 111.4 crore rupees, up 61.4% from a year earlier.
Revenue climbed 24.4% to 1,394.2 crore rupees. EBITDA grew 56.4% to 212.4 crore rupees, and the EBITDA margin widened by 310 basis points to 15.2%. Profit before tax rose to 148.5 crore rupees from 94.6 crore rupees a year earlier.
The Nutrition and Health Solutions segment posted revenue of 270 crore rupees, up 50%, while its EBITDA rose 87%. The company expects growth in all three business segments in FY27 and is buying a 40% stake in ZettaOne Technologies for 189.2 crore rupees. The shares were up 4.1% at 631 rupees after the report, though they are still down 12% so far this year.
why it matters
The results matter mainly for the company and India's specialty chemicals sector. Higher realisations and steady volumes support revenue growth, while the ZettaOne deal extends the company's reach into electronics and semiconductor services.
tags
instruments
sources
- Jubilant Ingrevia Q2 results: Stock gains as much as 8% after Nutrition & Health Solutions aid earnings growth — TradingView, 27 October 2026 at 09:33 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗